首页> 美国卫生研究院文献>Journal of Drug Delivery >Enhanced Dendritic Cell-Mediated Antigen-Specific CD4+ T Cell Responses: IFN-Gamma Aids TLR Stimulation
【2h】

Enhanced Dendritic Cell-Mediated Antigen-Specific CD4+ T Cell Responses: IFN-Gamma Aids TLR Stimulation

机译:增强的树突状细胞介导的抗原特异性CD4 + T细胞应答:IFN-γ有助于TLR刺激

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Phenotypic maturation and T cell stimulation are two functional attributes of DCs critical for immune induction. The combination of antigens, including those from cancer, with Toll-like receptor (TLR) ligands induces far superior cellular immune responses compared to antigen alone. In this study, IFN-gamma treatment of bone marrow-derived DC, followed by incubation with the TLR2, TLR4, or TLR9 agonists, enhanced DC activation compared to TLR ligation alone. Most notably, the upregulation of CD40 with LPS stimulation and CD86 with CpG stimulation was observed in in vitro cultures. Similarly, IFN-gamma coinjected with TLR ligands was able to promote DC activation in vivo, with DCs migrating from the site of immunization to the popliteal lymph nodes demonstrating increased expression of CD80 and CD86. The heightened DC activation translated to a drastic increase in T cell stimulatory capacity in both antigen independent and antigen dependent fashions. This is the first time that IFN-gamma has been shown to have a combined effect with TLR ligation to enhance DC activation and function. The results demonstrate the novel use of IFN-gamma together with TLR agonists to enhance antigen-specific T cell responses, for applications in the development of enhanced vaccines and drug targets against diseases including cancer.
机译:表型成熟和T细胞刺激是DC对免疫诱导至关重要的两个功能属性。与单独的抗原相比,抗原(包括来自癌症的抗原)与Toll样受体(TLR)配体的结合可诱导更好的细胞免疫应答。在这项研究中,与单独的TLR结扎相比,IFN-γ治疗骨髓源性DC,然后与TLR2,TLR4或TLR9激动剂一起孵育,可增强DC激活。最值得注意的是,在体外培养物中观察到LPS刺激下CD40和CpG刺激下CD86的上调。同样,与TLR配体共注射的IFN-γ能够在体内促进DC活化,DC从免疫部位迁移到the淋巴结,这表明CD80和CD86的表达增加。增强的DC活化以抗原非依赖性和抗原依赖性方式转化为T细胞刺激能力的急剧增加。这是首次证明IFN-γ与TLR连接具有增强DC激活和功能的联合作用。结果证明,IFN-γ与TLR激动剂一起用于增强抗原特异性T细胞应答的新颖用途,用于开发针对包括癌症在内的疾病的增强疫苗和药物靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号